Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Graythan Regulatory Services is an Australian consulting firm specializing in regulatory affairs, product development, program management, medical writing, and gene therapy application support for the biopharmaceutical industry. The company has a strong track record of successful submissions and registrations globally and offers expertise particularly in readying stalled or legacy products for clinical entry or marketing approval. They also operate one of Brisbane’s only non-university-based Institutional Biosafety Committees (IBC) to review gene technology license applications before submission to the Office of Gene Technology Regulator (OGTR).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Graythan Regulatory Services.